Cancer BiologybioRxiv
Precision combination therapies based on recurrent oncogenic co-alterations
X. Li, E. Dowling, G. Yan…·A. Korkut
The paper develops REFLECT, a method that maps recurrent co-alteration signatures to drug combinations using multi-omic data, validating its effectiveness across 201 cohorts and 10,392 patients.
DOI 10.1158/2159-8290.cd-21-0832